An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer

Mohammad Sultan, Jacob T. Nearing, Justin M. Brown, Thomas T. Huynh, Brianne M. Cruickshank, Emily Lamoureaux, Dejan Vidovic, Margaret L. Dahn, Wasundara Fernando, Krysta M. Coyle, Carman A. Giacomantonio, Morgan G.I. Langille, Paola Marcato

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)2046-2064
Number of pages19
JournalMolecular Oncology
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Genetics
  • Molecular Medicine
  • Oncology
  • Cancer Research

Keywords

  • BCL6
  • biomarkers
  • breast cancer
  • paclitaxel
  • shRNA screen

Fingerprint

Dive into the research topics of 'An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer'. Together they form a unique fingerprint.

Cite this